The dose escalation schedule spans 16 to 20 weeks: 0.25 mg for four weeks, 0.5 mg for four weeks, 1.0 mg for four weeks, 1.7 mg for four weeks, and finally 2.4 mg as the maintenance dose
Patients without BMI restrictions
Weight loss becomes transactional not transformative
When all of this happens together, the weight-loss process feels smoother and less stressful
Ozempic (semaglutide) shows huge reductions in high-risk heavy drinking, in first-ever clinical trial Powerful findings in Christian Hendershot's RCT w/ 48 non-treatment seekers and relatively low doses of semaglutide
Oral administration of glutathione is not as effective at increasing glutathione levels in the body as injection or inhalation, but it is generally considered safe and may have some potential health benefits